255 related articles for article (PubMed ID: 11601895)
41. [Construction of an adenoassociated, viral derived, expression vector to correct the genetic defect in Morquio A disease].
Gutiérrez MA; García-Vallejo F; Tomatsu S; Cerón F; Alméciga-Díaz CJ; Domínguez MC; Barrera LA
Biomedica; 2008 Sep; 28(3):448-59. PubMed ID: 19034368
[TBL] [Abstract][Full Text] [Related]
42. DNA helicase-mediated packaging of adeno-associated virus type 2 genomes into preformed capsids.
King JA; Dubielzig R; Grimm D; Kleinschmidt JA
EMBO J; 2001 Jun; 20(12):3282-91. PubMed ID: 11406604
[TBL] [Abstract][Full Text] [Related]
43. New helper cells and matched early region 1-deleted adenovirus vectors prevent generation of replication-competent adenoviruses.
Fallaux FJ; Bout A; van der Velde I; van den Wollenberg DJ; Hehir KM; Keegan J; Auger C; Cramer SJ; van Ormondt H; van der Eb AJ; Valerio D; Hoeben RC
Hum Gene Ther; 1998 Sep; 9(13):1909-17. PubMed ID: 9741429
[TBL] [Abstract][Full Text] [Related]
44. Cross-packaging of a single adeno-associated virus (AAV) type 2 vector genome into multiple AAV serotypes enables transduction with broad specificity.
Rabinowitz JE; Rolling F; Li C; Conrath H; Xiao W; Xiao X; Samulski RJ
J Virol; 2002 Jan; 76(2):791-801. PubMed ID: 11752169
[TBL] [Abstract][Full Text] [Related]
45. Quantitative comparison of expression with adeno-associated virus (AAV-2) brain-specific gene cassettes.
Xu R; Janson CG; Mastakov M; Lawlor P; Young D; Mouravlev A; Fitzsimons H; Choi KL; Ma H; Dragunow M; Leone P; Chen Q; Dicker B; During MJ
Gene Ther; 2001 Sep; 8(17):1323-32. PubMed ID: 11571569
[TBL] [Abstract][Full Text] [Related]
46. Stabilization of transgenes delivered by recombinant adenovirus vectors through extrachromosomal replication.
Krougliak VA; Krougliak N; Eisensmith RC
J Gene Med; 2001; 3(1):51-8. PubMed ID: 11269336
[TBL] [Abstract][Full Text] [Related]
47. Encapsidation of adeno-associated virus type 2 Rep proteins in wild-type and recombinant progeny virions: Rep-mediated growth inhibition of primary human cells.
Kube DM; Ponnazhagan S; Srivastava A
J Virol; 1997 Oct; 71(10):7361-71. PubMed ID: 9311814
[TBL] [Abstract][Full Text] [Related]
48. Efficient integration of recombinant adeno-associated virus DNA vectors requires a p5-rep sequence in cis.
Philpott NJ; Giraud-Wali C; Dupuis C; Gomos J; Hamilton H; Berns KI; Falck-Pedersen E
J Virol; 2002 Jun; 76(11):5411-21. PubMed ID: 11991970
[TBL] [Abstract][Full Text] [Related]
49. Liver-directed gene expression using recombinant AAV 2/8 vectors--a tolerogenic strategy for gene delivery?
Sharland A; Logan GJ; Bishop A; Alexander IE
Discov Med; 2010 Jun; 9(49):519-27. PubMed ID: 20587341
[TBL] [Abstract][Full Text] [Related]
50. Characterization of wild-type adeno-associated virus type 2-like particles generated during recombinant viral vector production and strategies for their elimination.
Wang XS; Khuntirat B; Qing K; Ponnazhagan S; Kube DM; Zhou S; Dwarki VJ; Srivastava A
J Virol; 1998 Jul; 72(7):5472-80. PubMed ID: 9621003
[TBL] [Abstract][Full Text] [Related]
51. Stable transduction of actively dividing cells via a novel adenoviral/episomal vector.
Leblois H; Roche C; Di Falco N; Orsini C; Yeh P; Perricaudet M
Mol Ther; 2000 Apr; 1(4):314-22. PubMed ID: 10933949
[TBL] [Abstract][Full Text] [Related]
52. Effect of genome size on AAV vector packaging.
Wu Z; Yang H; Colosi P
Mol Ther; 2010 Jan; 18(1):80-6. PubMed ID: 19904234
[TBL] [Abstract][Full Text] [Related]
53. Packaging of an AAV vector encoding human acid alpha-glucosidase for gene therapy in glycogen storage disease type II with a modified hybrid adenovirus-AAV vector.
Sun B; Chen YT; Bird A; Xu F; Hou YX; Amalfitano A; Koeberl DD
Mol Ther; 2003 Apr; 7(4):467-77. PubMed ID: 12727109
[TBL] [Abstract][Full Text] [Related]
54. Packaging capacity of adeno-associated virus serotypes: impact of larger genomes on infectivity and postentry steps.
Grieger JC; Samulski RJ
J Virol; 2005 Aug; 79(15):9933-44. PubMed ID: 16014954
[TBL] [Abstract][Full Text] [Related]
55. Inverted terminal repeat sequences are important for intermolecular recombination and circularization of adeno-associated virus genomes.
Yan Z; Zak R; Zhang Y; Engelhardt JF
J Virol; 2005 Jan; 79(1):364-79. PubMed ID: 15596830
[TBL] [Abstract][Full Text] [Related]
56. Human immunodeficiency virus type 1-mediated syncytium formation is compatible with adenovirus replication and facilitates efficient dispersion of viral gene products and de novo-synthesized virus particles.
Li H; Haviv YS; Derdeyn CA; Lam J; Coolidge C; Hunter E; Curiel DT; Blackwell JL
Hum Gene Ther; 2001 Dec; 12(18):2155-65. PubMed ID: 11779400
[TBL] [Abstract][Full Text] [Related]
57. Generation of a replication-deficient recombinant human adenovirus type 35 vector using bacteria-mediated homologous recombination.
Wu C; Lei X; Wang J; Hung T
J Virol Methods; 2011 Oct; 177(1):55-63. PubMed ID: 21763350
[TBL] [Abstract][Full Text] [Related]
58. Adeno-associated virus (AAV) Rep protein enhances the generation of a recombinant mini-adenovirus (Ad) utilizing an Ad/AAV hybrid virus.
Sandalon Z; Gnatenko DV; Bahou WF; Hearing P
J Virol; 2000 Nov; 74(22):10381-9. PubMed ID: 11044082
[TBL] [Abstract][Full Text] [Related]
59. Enhanced adeno-associated virus vector expression by adenovirus protein-cationic liposome complex. A novel and high efficient way to introduce foreign DNA into endothelial cells.
Zhou H; Zeng G; Zhu X; Tang J; Chen G; Huang Q; Peng T; Hu B
Chin Med J (Engl); 1995 May; 108(5):332-7. PubMed ID: 7555232
[TBL] [Abstract][Full Text] [Related]
60. Genetic targeting of an adenovirus vector via replacement of the fiber protein with the phage T4 fibritin.
Krasnykh V; Belousova N; Korokhov N; Mikheeva G; Curiel DT
J Virol; 2001 May; 75(9):4176-83. PubMed ID: 11287567
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
